Universal Health price target lowered to $163 from $165 at Citi

Citi analyst Jason Cassorla lowered the firm’s price target on Universal Health to $163 from $165 and keeps a Buy rating on the shares. The company reported a solid Q3 print with some upside, as Acute hung in against the pressured physician expense backdrop and mix-related seasonality, while Behavioral saw margin expansion, the analyst tells investors in a research note.